ES2055249T3 - Procedimiento para la preparacion de compuestos heterociclicos perfluorados, y los compuestos preparados segun este procedimiento. - Google Patents

Procedimiento para la preparacion de compuestos heterociclicos perfluorados, y los compuestos preparados segun este procedimiento.

Info

Publication number
ES2055249T3
ES2055249T3 ES90116140T ES90116140T ES2055249T3 ES 2055249 T3 ES2055249 T3 ES 2055249T3 ES 90116140 T ES90116140 T ES 90116140T ES 90116140 T ES90116140 T ES 90116140T ES 2055249 T3 ES2055249 T3 ES 2055249T3
Authority
ES
Spain
Prior art keywords
procedure
compounds
hetero
perfluored
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90116140T
Other languages
English (en)
Inventor
Hasso Meinert
Rudolf Fackler
Jurgen Mader
Peter Reuter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kali Chemie AG
Original Assignee
Kali Chemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie AG filed Critical Kali Chemie AG
Application granted granted Critical
Publication of ES2055249T3 publication Critical patent/ES2055249T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/05Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/07Oxygen containing compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/09Nitrogen containing compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/11Halogen containing compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/20Processes
    • C25B3/27Halogenation
    • C25B3/28Fluorination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO SE REFIERE A UNOS COMPUESTOS HETEROCICLICOS DE FORMULA (IA) O (IB) Y SUS MEZCLAS, TRATA DE UN PROCEDIMIENTO QUE SE UTILIZA PARA PRODUCIR UN COMPUESTO DE FORMULA (IA) O (IB) Y CONSISTE EN PERFLUORAR ELECTROQUIMICAMENTE LOS DERIVADOS DE CICLOALQUENILO; RESEÑA UN PRODUCTO OBTENIDO SEGUN EL PROCEDIMIENTO COMO EL PERFLUORO-N-CICLOHEXILO-MORFOLINA Y DESCRIBE LA APLICACION DEL COMPUESTO DE FORMULA (IA) O (IB) PARA LA PRODUCCION DE EMULSIONES ACUOSAS UTILIZABLES EN MEDICINA COMO MEDIOS PARA LA FORMACION DE SANGRE HUMANA. SIENDO X, -CF2-O-CF2, -CF2-CF2-CF2 O -CF(CF3)-CF2-; Y M 3 O 4.
ES90116140T 1989-08-30 1990-08-23 Procedimiento para la preparacion de compuestos heterociclicos perfluorados, y los compuestos preparados segun este procedimiento. Expired - Lifetime ES2055249T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3928692 1989-08-30
DE3941515 1989-12-15

Publications (1)

Publication Number Publication Date
ES2055249T3 true ES2055249T3 (es) 1994-08-16

Family

ID=25884570

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90116140T Expired - Lifetime ES2055249T3 (es) 1989-08-30 1990-08-23 Procedimiento para la preparacion de compuestos heterociclicos perfluorados, y los compuestos preparados segun este procedimiento.

Country Status (7)

Country Link
US (2) US5091064A (es)
EP (1) EP0415264B1 (es)
JP (1) JP2983593B2 (es)
AT (1) ATE107925T1 (es)
DE (2) DE4019061A1 (es)
DK (1) DK0415264T3 (es)
ES (1) ES2055249T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0492823A3 (en) * 1990-12-26 1992-11-19 Minnesota Mining And Manufacturing Company Perfluorinated t-amino cyclic ethers
US5162384A (en) * 1991-09-13 1992-11-10 Minnesota Mining And Manufacturing Company Making foamed plastic containing perfluorinated heterocyclic blowing agent
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5352785A (en) * 1993-03-30 1994-10-04 Minnesota Mining And Manufacturing Company Continuous process for purifying perfluorochemical compositions
CH686134A5 (de) * 1994-05-10 1996-01-15 Lonza Ag Gampel Wallis Geschof Tertiores Diamin, Verwendung als Katalysator und Verfahren zur Herstellung von tertioren Diaminen.
US20010055809A1 (en) * 1998-01-30 2001-12-27 Harpal S. Mangat Extending tissue preservation
KR20030076593A (ko) 2000-12-29 2003-09-26 오뜨끄리또에 악찌오네르노에 오브셰스뜨보 나우취노-쁘로이즈보드스뜨벤나야 피르마 "뻬르프또란" 가스 전달 에멀젼용 기재로서 사용되는 퍼플루오르화된사이클을 포함하는 3차 아민 및 이의 제조방법
CN112226783B (zh) * 2020-10-27 2022-03-08 浙江诺亚氟化工有限公司 一种电化学联合氟化工艺
WO2025068961A1 (en) * 2023-09-29 2025-04-03 Fluorinnovation L.L.C-Fz New apparatus and related new process for the manufacture of poly- and perfluorinated organic compounds by electrofluorination (ecf)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE275079C (es) *
NL7400407A (es) * 1973-01-17 1974-07-19
GB1573660A (en) * 1977-06-09 1980-08-28 Ici Ltd Perluoro-2,3,4,5-tetramethyl-3-ethyl tetrahydrofuran and its use as an inert fluid
JPS5518539A (en) * 1978-07-21 1980-02-08 Agency Of Ind Science & Technol Perfluoro(4-methyl-2-oxa-bi-cyclo4.4.0decane) and preparation thereof
EP0077114B1 (en) * 1981-09-08 1987-12-02 Green Cross Corporation Perfluorochemicals, process for preparing the same and their use as blood substitutes
US4530926A (en) * 1982-06-29 1985-07-23 The Green Cross Corporation Perfluorotricyclic amines as oxygen carriers
US4534978A (en) * 1982-12-28 1985-08-13 The Green Cross Corporation Perfluorocycloamines
US4766261A (en) * 1984-09-17 1988-08-23 Adamantech, Inc. Purification of fluorocarbons
GB8504916D0 (en) * 1985-02-26 1985-03-27 Isc Chemicals Ltd Emulsions of perfluorocarbons in aqueous media
DD275079A1 (de) * 1986-09-11 1990-01-10 Akad Wissenschaften Ddr Verfahren zur herstellung perfluorierter dicyclischer amine

Also Published As

Publication number Publication date
JP2983593B2 (ja) 1999-11-29
DE59006295D1 (de) 1994-08-04
DE4019061A1 (de) 1991-03-07
EP0415264A3 (en) 1991-05-02
US5091064A (en) 1992-02-25
US5173512A (en) 1992-12-22
DK0415264T3 (da) 1994-07-25
EP0415264A2 (de) 1991-03-06
ATE107925T1 (de) 1994-07-15
JPH03169855A (ja) 1991-07-23
EP0415264B1 (de) 1994-06-29

Similar Documents

Publication Publication Date Title
MX9204006A (es) Derivados de la 3-aril-4-hidroxi-delta3-dihidrofuranona y de la 3-aril-4-hidroxi-delta3-dihidrotiofenona y procedimiento para su obtencion.
ES2061858T3 (es) Derivados sustituidos en posicion 7 del acido 3,5-dihidroxihept-6-inoico, procedimiento para su preparacion, su empleo como medicamentos, asi como productos intermedios.
ES2093979T3 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion.
ES2086505T3 (es) Procedimiento de preparacion de un derivado n-fenilacetico de tetrahidrotieno(3,2-c)piridina y su producto intermedio de sintesis.
ES2052556T3 (es) Fungicidas.
MX9306303A (es) Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
GT198064354A (es) Derivados de 1,2,4 triazol,procedimiento para su produccion,asi como su aplicacion como fungicida
MX9204111A (es) Triazoles substituidos y procedimiento para su obtencion.
ES2017839A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales>
ES2115096T3 (es) Derivados tetrazolicos de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
MX9305566A (es) Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
ES2055249T3 (es) Procedimiento para la preparacion de compuestos heterociclicos perfluorados, y los compuestos preparados segun este procedimiento.
MX9303466A (es) Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2130472T3 (es) Guanididas de acidos alquenilcarboxilicos sustituidas con fenilo, portadoras de grupos perfluoroalquilo, procedimiento para su preparacion, su uso como medicamento o agente diagnostico, asi como medicamento que las contiene.
MX9204094A (es) Derivados de fenilalquilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES497382A0 (es) Un procedimiento para la preparacion de acidos 6-(1-hidroxietil)-2-2(2-aminoetiltio)-1-carbadetiapen-2-em-3-carboxilicos1,1-di-susitituidos.
ES8303404A1 (es) Procedimiento para preparar 3-amino-sidnoniminas sustituidas.
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
MX9304961A (es) Esteres del acido piridiloxi-acrilico y procedimiento para su obtencion.
ES8603243A1 (es) Un procedimiento para la preparacion de agentes antifungicos de triazol.
ES2054738T3 (es) Derivados de acido 3-desmetil-4-fluoromevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su empleo y productos intermedios.
ES8407476A1 (es) Procedimiento de preparar compuestos piridinicos.
AR248406A1 (es) 4-sulfonilamino-2-azinil-1, 2, 4-triazol-3-onas substituidas, procedimiento asi como productos intermediarios para su obtencion y su empleo como herbicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 415264

Country of ref document: ES